Jean M. Tersak
Advanced in Embryonal Tumor with Multilayered Rosettes
Advanced in Embryonal Tumor with Multilayered Rosettes
4401 Penn Avenue, 
Pittsburgh, PA 

Overview

Jean M. Tersak, MD, provides care for pediatric oncology patients and long term survivors of childhood cancer at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is institutional principal investigator for the UPMC Children’s Oncology Group and director of clinical oncology research within the Division of Pediatric Hematology/Oncology. She is also a professor of pediatrics and clinical and translational science at the University of Pittsburgh School of Medicine and is board-certified in pediatric hematology/oncology. Dr. Tersak earned her bachelor's degree, master’s degree, and  medical degree from the University of Pittsburgh. She completed her residency and fellowship at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis. Her research interests include the late effects, quality of life, and neurocognitive outcomes in survivors of childhood cancer and evaluation and treatment of opsoclonus myoclonus in patients with neuroblastoma. She is a member of the American Society of Clinical Oncology Children’s Oncology Group. View the full list of Dr. Tersak’s publications on PubMed.

Dr. Tersak is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Neuroepithelioma, Neuroblastoma, Histiocytosis, Bone Marrow Aspiration, and Splenectomy.

Her clinical research consists of co-authoring 15 peer reviewed articles and participating in 62 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article and participated in 28 clinical trials in the study of Embryonal Tumor with Multilayered Rosettes.

Graduate Institution
University Of Pittsburgh School Of Medicine
Residency
University of Pittsburgh School of Medicine
Specialties
Pediatric Hematology Oncology
Licenses
Specialist in PA
Board Certifications
American Board Of Pediatrics
Fellowships
University of Pittsburgh School of Medicine
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 7 Less Insurance Carriers -

Locations

Pediatric Hematology Oncology in Lawrenceville
4401 Penn Avenue, Pittsburgh, PA 15224

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


60 Clinical Trials

A Pilot Induction Regimen Incorporating Chimeric 14.18 Antibody (ch14.18, Dinutuximab) (NSC# 764038) and Sargramostim (GM-CSF) for the Treatment of Newly Diagnosed High-Risk Neuroblastoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Key Adverse Events After Childhood Cancer
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
View 49 Less Clinical Trials
Similar Doctors
James Felker
Experienced in Embryonal Tumor with Multilayered Rosettes
Pediatric Hematology Oncology
Experienced in Embryonal Tumor with Multilayered Rosettes
Pediatric Hematology Oncology

Pediatric Hematology Oncology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

James Felker, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is assistant professor of medicine at the University of Pittsburgh School of Medicine. Dr. Felker received his medical degree from New York Medical College and completed his residency at Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago followed by a fellowship in pediatric hematology/oncology and neuro-oncology at Emory University/Children’s Healthcare of Atlanta, Ga. Dr. Felker’s clinical interests include pediatric brain and spinal tumors and clinical trial development. He has published numerous articles in peer-reviewed journals and is a member of the American Society of Pediatric Hematology/Oncology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, and the Pediatric Brain Tumor Consortium. His wife is a pediatric cardiologist at UPMC Children’s and has an interest in long term cardiac outcomes for oncology patients. Together they have two girls and a beagle mutt. Dr Felker enjoys running along the rivers in Pittsburgh while trying to avoid the hills. View the full list of Dr. Felker's publications on PubMed. View Dr. Felker's profile at the University of Pittsburgh School of Medicine – Department of Pediatrics. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Felker is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Brain Stem Cancer, Glioma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.

Experienced in Embryonal Tumor with Multilayered Rosettes
Pediatric Hematology Oncology
Experienced in Embryonal Tumor with Multilayered Rosettes
Pediatric Hematology Oncology
3420 5th Ave, 
Pittsburgh, PA 
 (1.9 miles away)
Languages Spoken:
English

Julia Segal is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Segal is rated as an Experienced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Histiocytosis, Reticulohistiocytoma, Neuroblastoma, and Hemophagocytic Lymphohistiocytosis.

Experienced in Embryonal Tumor with Multilayered Rosettes
Pediatric Hematology Oncology
Experienced in Embryonal Tumor with Multilayered Rosettes
Pediatric Hematology Oncology
4401 Penn Ave, AOB Suite 5400, 
Pittsburgh, PA 
 (0.1 miles away)
Languages Spoken:
English

Lindsay Blazin is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Blazin is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tersak's expertise for a condition
ConditionClose
      View All 17 Advanced Conditions
      View All 27 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile